Literature DB >> 28969977

Partners in Crime: Phenolic Glycolipids and Macrophages.

Alok Kumar Singh1, William R Bishai2.   

Abstract

Two recent articles advance our understanding of mycobacterial pathogenesis, revealing key roles for bacterially derived phenolic glycolipids (PGLs). In leprosy, Mycobacterium leprae PGL-1 uniquely subverts local macrophages to produce neurotoxic nitric oxide (NO), leading to nerve demyelination. In a related model, Mycobacterium marinum PGL stimulates the recruitment of growth-conducive monocytes to sites of initial infection as an early immune evasion strategy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28969977      PMCID: PMC5687990          DOI: 10.1016/j.molmed.2017.09.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  10 in total

Review 1.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Structure of the major triglycosyl phenol-phthiocerol of Mycobacterium tuberculosis (strain Canetti).

Authors:  M Daffé; C Lacave; M A Lanéelle; G Lanéelle
Journal:  Eur J Biochem       Date:  1987-08-17

3.  Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae.

Authors:  V Ng; G Zanazzi; R Timpl; J F Talts; J L Salzer; P J Brennan; A Rambukkana
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

4.  The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-L-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice.

Authors:  Nicole A Terpolilli; Klaus Zweckberger; Raimund Trabold; Lothar Schilling; Reinhard Schinzel; Frank Tegtmeier; Nikolaus Plesnila
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

5.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.

Authors:  Michael B Reed; Pilar Domenech; Claudia Manca; Hua Su; Amy K Barczak; Barry N Kreiswirth; Gilla Kaplan; Clifton E Barry
Journal:  Nature       Date:  2004-09-02       Impact factor: 49.962

6.  The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence.

Authors:  Daniel Sinsimer; Gaelle Huet; Claudia Manca; Liana Tsenova; Mi-Sun Koo; Natalia Kurepina; Bavesh Kana; Barun Mathema; Salvatore A E Marras; Barry N Kreiswirth; Christophe Guilhot; Gilla Kaplan
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

7.  A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity.

Authors:  S W Hunter; P J Brennan
Journal:  J Bacteriol       Date:  1981-09       Impact factor: 3.490

8.  A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy.

Authors:  Cressida A Madigan; C J Cambier; Kindra M Kelly-Scumpia; Philip O Scumpia; Tan-Yun Cheng; Joseph Zailaa; Barry R Bloom; D Branch Moody; Stephen T Smale; Alvaro Sagasti; Robert L Modlin; Lalita Ramakrishnan
Journal:  Cell       Date:  2017-08-24       Impact factor: 41.582

9.  Phenolic Glycolipid Facilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages.

Authors:  C J Cambier; Seónadh M O'Leary; Mary P O'Sullivan; Joseph Keane; Lalita Ramakrishnan
Journal:  Immunity       Date:  2017-08-24       Impact factor: 31.745

Review 10.  Salmonella--the ultimate insider. Salmonella virulence factors that modulate intracellular survival.

Authors:  J Antonio Ibarra; Olivia Steele-Mortimer
Journal:  Cell Microbiol       Date:  2009-09-23       Impact factor: 3.715

  10 in total
  1 in total

Review 1.  Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection.

Authors:  Andreu Garcia-Vilanova; John Chan; Jordi B Torrelles
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.